Gene Query: MRPL13

Dataset Description Geneva Score
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 61.33
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 31.36
Systematic discovery of endogenous human ribonucleoprotein complexes 28.63
Cleavage Factor Im as a key regulator of 3’ UTR length 25.56
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 25.15
RNA-seq analyses of human prostate cancer cells 24.49
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 21.2
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 21.05
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 20.93
DART-seq: an antibody-free method for global m6A detection 20.51
Transcriptomic analyssis following EHMT1/2 inhibition 20.47
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 20.47
SLAM-seq for K562 endogenous mRNA decay 18.95
Unique features and clinical importance of acute alloreactive immune responses 17.43
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 17.08
IDH3a KO RNA-seq 16.87
Identification of transcription start sites for human A549 cell line using ReCappable-seq 16.19
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 16.02
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 15.9
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 15.8
Regulation of protein translation during mitosis 15.69
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 15.56
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 15.52
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 15.26
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 14.57
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 14.57
Comprehensive comparative analysis of 5’ end RNA sequencing methods 14.35
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 14.34
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 14.22
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 13.95
Oncogenic roles of ARID5B in T-ALL 13.74
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 13.74
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 13.73
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 13.57
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 13.28
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 13.25
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 13.11
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 12.89
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 12.59
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 12.59
hnRNP C is a key regulator of protein synthesis in mitosis 12.4
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 12.38
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 12.34
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 12.34
Tracking distinct RNA populations using efficient and reversible covalent chemistry 12.27
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 12.15
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 12.11
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 11.99
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 11.96
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 11.95
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 11.91
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 11.91
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 11.57
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 11.5
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 11.5
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 11.39
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 11.39
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 11.35
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 11.35
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 11.2
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 11.07
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 10.89
MOF acetyl transferase regulates transcription and respiration in mitochondria 10.84
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 10.52
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 10.43
Integrin signaling regulates YAP/TAZ to control skin homeostasis 10.38
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 10.37
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 10.3
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 10.15
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 10.09
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 9.87
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 9.85
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 9.61
Patient-derived luminal breast cancer xenografts with progestins 9.59
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 9.59
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 9.54
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 9.49
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 9.35
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 9.33
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 9.33
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 9.33
Transcription control by the ENL YEATS domain in acute leukemia 9.23
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 9.23
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 8.99
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 8.97
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 8.88
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 8.87
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 8.84
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 8.8
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 8.79
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 8.78
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 8.69
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 8.69
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 8.61
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 8.59
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 8.55
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 8.55
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 8.51
Generating Patterned Kidney Organoids for Studying Development and Diseases 8.49
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 8.36
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 8.34
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 8.34
CROP-Seq in Primary Human T Cells 8.29
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 8.23
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 8.23
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 8.21
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 8.19
Global analysis of enhancer targets: Mosaic-seq 8.18
Trans-differentiation of human adult peripheral blood T cells into neurons 8.05
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 7.93
A transcriptome-wide divergence in protein translation scales with LIN28B expression 7.92
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 7.86
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 7.82
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 7.81
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 7.81
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 7.8
Rorc disruption in human FG pancreatic cancer cells 7.71
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 7.68
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 7.63
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 7.63
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 7.62
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 7.56
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 7.54
Expression by CD133+ cells isolated from the adult human exocrine pancreas 7.51
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 7.5
HNF1A deficiency impairs β-cell fate, granule maturation and function 7.46
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 7.46
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 7.46
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 7.44
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 7.4
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 7.37
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 7.37
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 7.28
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  7.22
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 7.21
ETV7 and interferon response 7.21
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 7.14
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 7.11
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 7.06
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 7.01
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 7.01
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 7.0
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 6.94
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 6.94
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 6.91
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 6.86
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 6.85
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 6.74
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 6.69
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 6.64
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 6.63
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 6.58
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 6.57
Co-transcriptional loading of RNA export factors shapes the human transcriptome 6.56
RNAseq of HEK293 cells after Chtop knockdown 6.56
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 6.55
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 6.53
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 6.48
RNA-seq of RKO cells with cTAZ KO or putback 6.46
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 6.42
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 6.4
RNA sequencing of primary human platelets and in vitro cell lines 6.38
Lysine benzoylation is a novel histone mark 6.33
Lysine benzoylation is a novel histone mark [RNA-seq] 6.33
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 6.31
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 6.25
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 6.24
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 6.2
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 6.2
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 6.13
MicroRNA-125a-5p overexpression in human macrophages 6.06
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 6.05
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 6.04
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 6.03
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 6.03
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 6.01
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 6.01
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 5.99
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 5.97
Direct Isolation and Characterization of Human Nephron Progenitors. 5.89
Landscape and variation of RNA secondary structure across the human transcriptome 5.88
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 5.88
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 5.86
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 5.82
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 5.82
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 5.81
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 5.81
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 5.79
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 5.77
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 5.76
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 5.76
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 5.61
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 5.61
Small-molecule targeting of brachyury transcription factor addiction in chordoma 5.6
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 5.6
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 5.6
RNA-seq of resting and activated CD4+ T cells +-JQ1 5.53
Transcriptome landscape of HeLa response upon triamcinolone acetonide 5.53
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 5.52
Genome-wide chromatin analysis of Ewing sarcoma 5.52
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 5.49
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 5.49
A549 cells and MSR-A549 cells 5.49
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 5.49
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 5.48
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 5.47
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 5.43
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 5.42
Transcriptomic analysis of human tonsillar TFH subsets 5.4
Effect of CHKA knockdown on C4-2 cell transcriptome 5.39
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 5.39
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 5.39
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 5.38
EWSR1 influences alternative splicing through direct and indirect mechanisms 5.37
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 5.31
The cohesin complex prevents Myc-induced replication stress 5.28
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 5.27
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 5.27
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 5.27
Single-cell analysis of adult human ovary using 10X genomics 5.21
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 5.19
Effect of ILF3 on translation during homeostasis and the antiviral response 5.19
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 5.18
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 5.18
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 5.18
N6-methyladenine DNA Modification in Glioblastoma 5.1
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 5.1
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 5.09
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 5.09
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 5.04
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 5.04
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 5.04
RNA-seq analysis to identify the genes regulated by p53-SET interplay 5.04
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 5.03
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 4.98
RNA-Seq with and without RNase treatment in PCa cell lines 4.97
RNA sequencing of mechanically strained NHEKs and control NHEKs 4.95
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 4.95
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 4.95
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  4.95
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 4.93
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 4.93
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 4.91
RNA editing in nascent RNA affects pre-mRNA splicing 4.83
Total RNA-seq in ALL-SIL upon TLX1 knockdown 4.79
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 4.77
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 4.75
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 4.75
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 4.72
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 4.71
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 4.7
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 4.7
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 4.69
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 4.68
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 4.66
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 4.58
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 4.56
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 4.56
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 4.55
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 4.51
Single-cell analysis of human kidney organoids 4.5
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 4.5
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 4.5
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 4.45
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 4.44
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 4.41
O-glcnAc reprograms cellular energetics 4.41
Effect of PRDM11 depletion in U2932 cells 4.38
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 4.37
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 4.36
Solid phase chemistry to covalently and reversibly capture thiolated RNA 4.34
Triple vectors expand AAV transfer capacity in the retina 4.33
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 4.3
Iron response of HepG2 cells 4.26
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 4.22
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 4.2
HEK293 Heat-shock experiment 4.16
RNA-Seq of PRMT1 overexpression ECA109 cells 4.16
Transcriptome sequencing of K-562 cells 4.14
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 4.11
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 4.11
Effect of BB608 on Gene Expression in HNSCC Cell Line 4.11
Positively selected enhancer elements endow tumor cells with metastatic competence 4.1
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 4.07
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 4.04
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 4.01
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 4.0
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 3.99
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 3.97
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 3.97
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 3.96
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 3.96
The MEF2B Regulatory Network - RNA-seq data 3.9
The MEF2B Regulatory Network 3.9
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 3.88
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 3.88
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 3.85
mRNA expression profile of Lymphocytes 3.84
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 3.83
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 3.83
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 3.75
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 3.74
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 3.73
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 3.67
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 3.64
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 3.64
Ribosome profiling upon inhibition of eIF4A 3.64
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 3.62
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 3.62
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 3.61
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 3.59
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 3.58
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 3.56
Epigenetic reprogramming of melanoma cells by vitamin C treatment 3.51
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 3.49
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 3.47
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 3.44
Transcriptional changes in lymphoma cells induced by LSD1 depletion 3.44
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 3.44
RNA-sequencing in immortalized human mammary epithelial cells 3.44
JunB control of keratinocyte-mediated inflammation [RNA-seq] 3.43
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 3.43
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 3.38
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 3.38
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 3.36
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.32
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 3.31
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 3.22
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 3.21
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 3.19
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 3.14
p63 controls the enhancer landscape during keratinocyte differentiation 3.13
Gene expression profile in breast cancer cells 3.12
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 3.12
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 3.11
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 3.11
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 3.11
Gene expression changes caused by KRAS in MCF-10A 3.08
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 3.08
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 3.07
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 3.07
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 3.07
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 3.07
RNA-seq data 3.05
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 3.04
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 3.04
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 3.04
SLIGRL-induced gene expression changes in NHEK cells 3.03
Peptidomimetic blockade of MYB in acute myeloid leukemia 2.99
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 2.99
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 2.92
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 2.9
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 2.88
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 2.86
MCF-7 as a model for functional analysis of breast cancer risk variants 2.84
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 2.82
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 2.78
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 2.78
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 2.78
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 2.76
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 2.73
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 2.71
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 2.71
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 2.69
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 2.68
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 2.63
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 2.6
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 2.59
PRDM1 inhibits proliferation of human colon cancer organoids 2.57
The Genetic Landscape of Diamond-Blackfan Anemia 2.52
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 2.46
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 2.45
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 2.43
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 2.43
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 2.43
Human cells contain natural double-stranded RNAs with potential regulatory capacity 2.42
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 2.42
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 2.42
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 2.42
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 2.4
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 2.39
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 2.39
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 2.33
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 2.33
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 2.29
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 2.27
Regulation of hypoxia-inducible factor activity by ZMYND8 2.21
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 2.21
Real-time observation of light-controlled transcription in living cells 2.18
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.16
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 2.15
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 2.12
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 2.03
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 1.99
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 1.93
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 1.93
Generation and persistence of human tissue-resident memory T cells in lung transplantation 1.9
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 1.89
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 1.87
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.84
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 1.8
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.8
Transcriptional landscape changes during human embryonic stem cell derivation 1.75
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 1.74
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 1.72
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 1.71
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 1.58
Chromatin landscape of human visceral and subcutaneous adipocytes 1.56
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 1.54
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 1.54
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 1.49
Gene Expression Profiling of WT and KDM3A Knocked out Cell 1.45
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 1.45
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 1.44
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 1.42
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 1.42
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 1.41
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 1.37
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 1.36
mRNA recovered upon RNF219 IP. [RNA-IP] 1.35
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 1.35
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.35
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 1.31
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 1.3
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 1.28
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.24
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 1.24
SF3B1 Degron knockdown RNA-seq 1.14
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 1.06
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.05
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.03
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 0.98
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 0.93
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 0.93
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 0.9
RNA seq with AML (NB4) cells upon FTO inhibition 0.9
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 0.89
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.89
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 0.83
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.82
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.76
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.76
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 0.75
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.75
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.74
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 0.74
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 0.72
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.71
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 0.66
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 0.65
6mer seed toxicity in viral microRNAs 0.61
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.59
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.59
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.59
siRNA-mediated knockdown 0.57
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 0.56
Role of cervicovaginal microbiota in genital inflammation 0.51
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 0.48
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.47
EGR1-controlled transcriptome of T HESCs 0.44
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 0.43
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.42
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 0.4
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 0.37
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 0.37
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 0.36
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 0.36
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.33
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.33
Global transcriptome analysis of WT versus HEB-/- hESCs 0.3
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.28
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 0.27
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.27
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.25
Myc activation coordinates gene transcription and protein translation responses 0.25
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.24
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 0.24
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.24
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.22
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.22
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 0.21
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.19
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.19
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.19
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.19
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 0.15
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.14
Dermal endothelial cells of type 2 diabetic patients 0.14
miRNAs affected by antagomiR-17 treatment 0.12
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 0.1
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.09
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.09
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.08
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.07
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.07
p53 activity results in DNA replication fork processivity 0.06
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 0.03
HEK293 TFAM Knockout Expression Study 0.02
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.0
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation